Research
Mixed
There is no significant sex difference in the relative risk of cancer mortality associated with diabetes; the risk increase is comparable for both men and women.
While diabetes increases your risk of cancer, this relative increase is similar for both men and women. Focus on standard cancer screening and healthy lifestyle habits rather than worrying about a sex-specific cancer risk amplification from diabetes.
StrongRefutesHIGH confidence
There was no evidence of a sex difference in the association between diabetes and cancer mortality; the pooled multiple-adjusted RRR of cancer mortality for diabetes was 1.02 (0.98 to 1.06; P = 0.21).
Why this rating
Meta-analysis of 14 studies with over 4.4 million participants.
Source
Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants
Yafeng Wang et al. · BMC Medicine · 2019
DOI 10.1186/s12916-019-1355-0
Meta-analysis · 49 studiesCited 212×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Women with diabetes face a 58% greater risk of coronary heart disease (CHD) mortality and a 13% greater risk of all-cause mortality compared to men with diabetes, indicating a significant sex-specific disparity in cardiovascular outcomes.Strong
- Women with diabetes have a 30% greater excess risk of cardiovascular disease (CVD) mortality compared to men with diabetes, driven largely by a higher risk of coronary heart disease (CHD) mortality.Strong
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →